NCT00347438 - Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Breast Cancer

Interventions

DRUG

Capecitabine

Capecitabine twice daily for 14 days followed by 7 days without taking drug (1 cycle). This schedule is followed for 8 cycles (about 24 weeks).

Trial Locations (3)

University of Chicago, Chicago

University of Ibadan, Ibadan

Obafemi Awolowo University, Ile-Ife